Marshall Wace’s CRISPR Therapeutics CRSP Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-393,295
| Closed | -$13.4M | – | 2617 |
|
|
2025
Q1 | $13.4M | Buy |
+393,295
| New | +$13.4M | 0.02% | 609 |
|
|
2024
Q3 | – | Sell |
-186,591
| Closed | -$10.1M | – | 2371 |
|
|
2024
Q2 | $10.1M | Buy |
+186,591
| New | +$10.1M | 0.01% | 659 |
|
|
2024
Q1 | – | Sell |
-3,200
| Closed | -$200K | – | 2190 |
|
|
2023
Q4 | $200K | Sell |
3,200
-132,747
| -98% | -$8.31M | ﹤0.01% | 1670 |
|
|
2023
Q3 | $6.17M | Sell |
135,947
-321,061
| -70% | -$14.6M | 0.01% | 722 |
|
|
2023
Q2 | $25.7M | Buy |
+457,008
| New | +$25.7M | 0.05% | 350 |
|
|
2022
Q4 | – | Sell |
-10,893
| Closed | -$712K | – | 2395 |
|
|
2022
Q3 | $712K | Buy |
+10,893
| New | +$712K | ﹤0.01% | 1923 |
|
|
2021
Q4 | – | Sell |
-255,727
| Closed | -$28.6M | – | 3217 |
|
|
2021
Q3 | $28.6M | Buy |
+255,727
| New | +$28.6M | 0.12% | 154 |
|
|
2020
Q2 | – | Sell |
-1,917
| Closed | -$81K | – | 1581 |
|
|
2020
Q1 | $81K | Sell |
1,917
-457
| -19% | -$19.3K | ﹤0.01% | 1347 |
|
|
2019
Q4 | $145K | Buy |
+2,374
| New | +$145K | ﹤0.01% | 1354 |
|
|
2018
Q2 | – | Sell |
-4,627
| Closed | -$212K | – | 722 |
|
|
2018
Q1 | $212K | Buy |
+4,627
| New | +$212K | 0.01% | 514 |
|